Airmony

MainImage

72,952.17€

Invested of 150,000.00€

Airmony, the first hoseless portable device to treat sleep apnea

Finish date: 28/05/2017 Barcelona

Premoney valuation

1,800,000.00€

Percentage offered

7.69%

Est. ROI

845%

Exit horizon

2022